Published: 1 January 2026PIBGeneral
Union Health Minister J.P. Nadda Releases 10th Edition of Indian Pharmacopoeia 2026
Union Health Minister J.P. Nadda released the 10th edition of the Indian Pharmacopoeia (IP 2026) at Dr. Ambedkar International Centre, New Delhi on January 2, 2026. The edition incorporates 121 new monographs, bringing the total to 3,340, with expanded coverage of anti-tubercular, anti-diabetic, and anti-cancer medicines along with 20 blood component standards.
A notable milestone in IP 2026 is the first-time inclusion of monographs for blood components used in transfusion medicine, aligning with provisions under the Drugs and Cosmetics (Second Amendment) Rules, 2020. The Indian Pharmacopoeia Commission (IPC) sets legally binding quality standards for drugs manufactured and marketed in India. The 10th edition reflects India's growing leadership in pharmaceutical manufacturing and regulation globally.
Mains angle
Q: Highlight the significance of the Indian Pharmacopoeia 2026 tenth edition for India's pharmaceutical regulation and global leadership.
Answer (50 words): Union Health Minister J.P. Nadda released the tenth edition of Indian Pharmacopoeia 2026 at Ambedkar International Centre on January 2, 2026. It adds 121 new monographs reaching 3,340 total, expanding anti-tubercular, anti-diabetic and anti-cancer coverage, and introduces twenty first-ever blood component standards aligned with Drugs and Cosmetics Second Amendment Rules 2020.
6-axis classification
CoverageNationalSubjectScience & TechnologyExamBasic Computer Instructor · CET Graduation · CET Senior Secondary · EO/RO · LDC · Mahila Supervisor · Patwar · PTI · RAS · REET · RPSC SI · School Lecturer · Senior Computer Instructor · Senior Teacher · UPSC · Vanpal · BothSourcePIB
Practice MCQ from this story
SolveTap an option below. Correct or incorrect feedback appears instantly.
Linked questionHard
The 10th edition of the Indian Pharmacopoeia (IP 2026) was released by Union Health Minister J.P. Nadda. How many total monographs does IP 2026 contain?
Explanation · Correct answer BThe 10th edition of the Indian Pharmacopoeia (IP 2026) was released on January 2, 2026. It incorporates 121 new monographs, bringing the total to 3,340, with expanded coverage of anti-tubercular, anti-diabetic, anti-cancer medicines and 20 blood component standards. It is legally enforceable under the Drugs and Cosmetics Act, 1940.
Frequently asked questions
Who released IP 2026 and where was it released?
Union Health Minister J.P. Nadda released the 10th edition of the Indian Pharmacopoeia (IP 2026) at Dr. Ambedkar International Centre, New Delhi on January 2, 2026.
How many monographs does Indian Pharmacopoeia 2026 include?
The edition incorporates 121 new monographs, bringing the total to 3,340. It expands coverage of anti-tubercular, anti-diabetic, and anti-cancer medicines along with 20 blood component standards.
What first-time blood component milestone is included in IP 2026?
IP 2026 includes monographs for blood components used in transfusion medicine for the first time. This aligns with provisions under the Drugs and Cosmetics (Second Amendment) Rules, 2020.
What role does the Indian Pharmacopoeia Commission play and what does the 10th edition reflect?
The Indian Pharmacopoeia Commission (IPC) sets legally binding quality standards for drugs manufactured and marketed in India. The 10th edition reflects India's growing leadership in pharmaceutical manufacturing and regulation globally.
